Abstract: A wireless communication system attests to user data from a wireless user device. The wireless user device receives satellite signals from satellites and determines satellite signal metrics for the satellite signals. The wireless user device determines its geographic location based on the satellite signals. The wireless user device executes an operating system in trusted processing circuitry in response to device power-up. The wireless user device executes a network application in the trusted processing circuitry. The network application transfers the user data, geographic location, and signal metrics to network elements. The network elements determine known satellite metrics for the geographic location. The network elements compare the satellite signal metrics to the known satellite metrics and generate an attestation score for the user data based on the satellite comparison. The network elements store the user data, the geographic location, and the attestation score.

Abstract: A wireless access node wirelessly transfers an identifier and location to a communication satellite. The communication satellite transfers the identifier and location to a data communication system. The data communication system determines a node configuration for the wireless access node based on the identifier and location and transfers the node configuration for the wireless access node to the communication satellite. The communication satellite wirelessly transfers the node configuration to the wireless access node. The wireless access node wirelessly exchanges user data with user communication devices based on the node configuration. The wireless access node exchanges the user data with the data communication system based on the node configuration.

Abstract: The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to 30 peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.

Abstract: The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to 30 peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.

Abstract: The invention relates to a data processing device for an imaging apparatus, the device being configured to obtain a length threshold value, to access input image data representing at least one digital input image, wherein the input image data comprise a shading signal representing a brightness decrease towards the edges of the at least one digital input image, and a content signal representing image features of the at least one digital input image, the image features having a length that is smaller than the length threshold value, to compute a baseline image based on the input image data and the length threshold value, wherein the baseline image is representative of an estimate of the shading signal, to generate at least one digital output image representative of an estimate of the content signal by at least one of a) subtracting the baseline image from the input image data and b) dividing the input image data by the baseline image.

Abstract: The invention relates to a wetting mechanism 20 for wetting a tube 12 of a catheter 10. The wetting mechanism 20 includes a housing 16 to be positioned at or proximal to the tip end 13 of the catheter tube 12, where the housing 16 comprises a holding chamber 22 and a wetting chamber 23. The wetting mechanism 20 comprises a fluid release control component 26 for controlling release of fluid within the holding chamber 22 into the wetting chamber 23. At least a portion of the catheter tube 12 is then able to be introduced and be moved through the wetting chamber 23 to wet the catheter tube 12, in use.

Abstract: The present invention relates to a catheter 10. The catheter 10 includes a catheter tube 12 having a tip end 13 and a distal end 14, with the distal end 14 being coupled to or forming at least part of a funnel 16 for discharging fluid from within the catheter tube 12. A sleeve 18 is provided about the catheter tube 12 which is coupled at an end thereof to the funnel 16 and extends towards the tip end 13 of the catheter tube 12. The catheter 10 additionally includes a wetting mechanism 20 which is integrally formed with the funnel 16 and includes a holding chamber 22 and a fluid outlet 26 operable to allow fluid 24 from within the holding chamber 22 to be released within the sleeve 18 for wetting an outer surface of the catheter tube 12.

Abstract: The invention relates to a wetting mechanism 20 for wetting a tube 12 of a catheter 10. The wetting mechanism 20 includes a housing 16 positioned initially at or proximal to the tip end 13 of the catheter tube 12. The housing 16 comprises a wetting chamber 23 into which at least a portion of the catheter tube 12 is able to be introduced and be moved therethrough to wet the catheter tube 12 in use. The wetting mechanism 20 includes a wetting applicator 40 positioned within the wetting chamber 23 configured to hold fluid therein and release said fluid to wet the catheter tube 12 upon movement of the tube 12 through the wetting chamber 23.

Abstract: The invention relates to a wetting mechanism 20 for wetting a tube 12 of a catheter 10. The wetting mechanism 20 includes a housing 16 positioned initially at or proximal to the tip end 13 of the catheter tube 12. The housing 16 comprises a wetting chamber 23 into which at least a portion of the catheter tube 12 is able to be introduced and be moved therethrough to wet the catheter tube 12 in use. The wetting mechanism 20 includes a stopper 26 which is moveable between a first and second positions to prevent or allow the tip end 13 of the catheter tube 12 to be moved through the wetting chamber 23.

Abstract: The present invention relates to packaging 10 for housing a medical device 100. The packaging 10 includes first and second sides 12, 14 sealed or otherwise secured around the periphery thereof to define a plurality of edges. An interaction region 24 is provided and defines a first point of contact for a user of the packaging 100. The packaging 10 also includes a tear-away region 28 which may be at least partially separated from the remainder of the packaging to form an open upper end of the packaging 10, in use. The tear-away region 28 includes an interaction point defining a second point of contact for a user of the packaging 10. A sealing arrangement including first and second sealing members 42, 44 provides a user-sealable seal between the first and second sides 12, 14 of the packaging 10.

Abstract: The invention relates to a wetting mechanism 20 for wetting a tube 12 of a catheter 10. The wetting mechanism 20 includes a housing 16 to be positioned at or proximal to the tip end 13 of the catheter tube 12, where the housing 16 comprises a holding chamber 22 and a wetting chamber 23. The wetting mechanism 20 comprises a fluid release control component 26 for controlling release of fluid within the holding chamber 22 into the wetting chamber 23. At least a portion of the catheter tube 12 is then able to be introduced and be moved through the wetting chamber 23 to wet the catheter tube 12, in use.

Abstract: The present invention relates to a catheter 10. The catheter 10 includes a catheter tube 12 having a tip end 13 and a distal end 14, with the distal end 14 being coupled to or forming at least part of a funnel 16 for discharging fluid from within the catheter tube 12. A sleeve 18 is provided about the catheter tube 12 which is coupled at an end thereof to the funnel 16 and extends towards the tip end 13 of the catheter tube 12. The catheter 10 additionally includes a wetting mechanism 20 which is integrally formed with the funnel 16 and includes a holding chamber 22 and a fluid outlet 26 operable to allow fluid 24 from within the holding chamber 22 to be released within the sleeve 18 for wetting an outer surface of the catheter tube 12.

Abstract: The invention relates to a wetting mechanism 20 for wetting a tube 12 of a catheter 10. The wetting mechanism 20 includes a housing 16 positioned initially at or proximal to the tip end 13 of the catheter tube 12. The housing 16 comprises a wetting chamber 23 into which at least a portion of the catheter tube 12 is able to be introduced and be moved therethrough to wet the catheter tube 12 in use. The wetting mechanism 20 includes a stopper 26 which is moveable between a first and second positions to prevent or allow the tip end 13 of the catheter tube 12 to be moved through the wetting chamber 23.

Abstract: The invention relates to a wetting mechanism 20 for wetting a tube 12 of a catheter 10. The wetting mechanism 20 includes a housing 16 positioned initially at or proximal to the tip end 13 of the catheter tube 12. The housing 16 comprises a wetting chamber 23 into which at least a portion of the catheter tube 12 is able to be introduced and be moved therethrough to wet the catheter tube 12 in use. The wetting mechanism 20 includes a wetting applicator 40 positioned within the wetting chamber 23 configured to hold fluid therein and release said fluid to wet the catheter tube 12 upon movement of the tube 12 through the wetting chamber 23.

Abstract: The present invention relates to packaging 10 for housing a medical device 100. The packaging 10 includes first and second sides 12, 14 sealed or otherwise secured around the periphery thereof to define a plurality of edges. An interaction region 24 is provided and defines a first point of contact for a user of the packaging 100. The packaging 10 also includes a tear-away region 28 which may be at least partially separated from the remainder of the packaging to form an open upper end of the packaging 10, in use. The tear-away region 28 includes an interaction point defining a second point of contact for a user of the packaging 10. A sealing arrangement including first and second sealing members 42, 44 provides a user-sealable seal between the first and second sides 12, 14 of the packaging 10.

Abstract: Disclosed is a solid arthropodicide composition comprising by weight (a) from 0.3 to 100% of a particulate component comprising particles of a solid carrier infiltrated with a mixture comprising (i) one or more carboxamide arthropodicides and (ii) a surfactant constituent; (b) from 0 to 50% of a surfactant component having dispersing and wetting properties; and (c) from 0 to 99.7% of one or more additional formulating ingredients. Also disclosed is a propagule contacted with a biologically effective amount of said composition.

Abstract: Disclosed are suspension concentrate compositions comprising by weight based on the total weight of the composition, about 0.1 to about 40% of at least one carboxamide arthropodicide; 0 to about 20% of at least one other biologically active agent; about 30 to about 95% of at least one water-immiscible liquid carrier; about 2 to about 50% of at least one emulsifier; about 0.01 to about 10% of a silica thickener; about 0.1 to about 10% of at least one protic solvent selected from water, a C1-C12 alkanol and a C2-C3 glycol; and about 0.001 to about 5% of at least one water-soluble carboxylic acid. A method for controlling an arthropod pest comprising diluting said suspension concentrate composition with water, and optionally adding an adjuvant to form a diluted composition, and contacting the arthropod pest or its environment with an effective amount of said diluted composition is also disclosed.

Abstract: Methods are provided for pelletizing a microbial biomass, extracting a refined lipid composition from the pelletized biomass under supercritical conditions and distilling the refined lipid composition, at least once under short path distillation conditions, to obtain a lipid-containing fraction. Also disclosed are methods of making lipid-containing oil concentrates therefrom, by transesterifying and enriching the lipid-containing fraction.

Abstract: Methods are provided for pelletizing a microbial biomass, extracting a refined lipid composition from the pelletized biomass under supercritical conditions and distilling the refined lipid composition, at least once under short path distillation conditions, to obtain a lipid-containing fraction. Also disclosed are methods of making lipid-containing oil concentrates therefrom, by transesterifying and enriching the lipid-containing fraction.

Abstract: A process including: (a) mixing a microbial biomass, comprising oil-containing microbes, and at least one grinding agent capable of absorbing oil, to provide a disrupted biomass mix; (b) blending at least one binding agent with said disrupted biomass mix to provide a fixable mix capable of forming a solid pellet; and, (c) forming the solid pellet from the fixable mix. The process optionally includes extracting the solid pellet with a solvent to provide an extracted microbial oil.